Kinase, in vitro: 

An enzyme-substrate reaction that occurs in non-living experimental conditions such as a test tube. For example, a purified enzyme is reacted with a substrate protein or mixture of proteins or peptides.

Akt1 S346-p
GRK2 S355-p , S356-p
GRK2 S355-p , S356-p , S396-p , S407-p , S411-p
GRK3 S355-p , S356-p
GRK5 S355-p , S356-p
GRK6 S355-p , S356-p
PKACA S261-p , S262-p
 Putative in vivo kinases: 

An enzyme-substrate reaction that occurs within living cells; includes cultured cells, ex vivo samples, and intact organisms. In the case of kinases, the large number of protein kinases in intact cells makes exact identification of the responsible kinase challenging.

Akt1 S346-p
GRK2 S355-p , S356-p
GRK2 T384-p , S396-p , S401-p , S407-p
GRK3 S355-p , S356-p
GRK5 S355-p , S356-p
GRK5 S355-p , S356-p , T384-p , T393-p , S396-p , S401-p , S407-p , S411-p
GRK6 S355-p , S356-p
PKACA S345-p , S346-p
Regulatory protein:
GRK2 S355-p , S356-p
GRK5 S355-p , S356-p
GRK6 S355-p , S356-p
Treatment:
(R,R')-4'-aminofenoterol S262-p , S355-p , S356-p
7PA2 CM T384-p
alpha-hederin S345-p , S346-p , S355-p , S356-p
alprostadil S262-p
angiotensin_2 S246-p
anti-CADM1 Y350-p
anti-SCF Y350-p
carazolol S262-p , S345-p , S346-p , S355-p , S356-p
carbachol S262-p
carvedilol S355-p , S356-p
colforsin S262-p , C265-pa , Y326-p , S345-p , S346-p , S355-p , S356-p
fenoterol S262-p
formoterol S355-p , S356-p
genistein Y350-p
H-89 S262-p , C265-pa
hypertonic_buffer S262-p
IBMX S262-p , C265-pa
ICI-118,551 S262-p , S345-p , S346-p , S355-p , S356-p
insulin Y141-p , S346-p
isoproterenol S262-p , C265-pa , Y326-p , S345-p , S346-p , S355-p , S356-p , T360-p , S364-p
KT5720 S345-p , S346-p
methoxyfenoterol S262-p
phorbol_ester S262-p
propranolol S355-p , S356-p
racepinefrine S262-p , S355-p , S356-p , S364-p
Rp-cAMPS S345-p , S346-p
salbutamol S262-p , S355-p , S356-p
salmeterol S355-p , S356-p
SCF Y350-p
TRH S355-p , S356-p
U0126 S262-p , C265-pa